Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPAR-gamma agonist treatment in familial partial lipodystrophy with PPARG mutations
NL-OMON34111Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2010
- Countries
- 1
01
Overview
Open-label trial in familial partial lipodystrophy (FPLD) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Clinical features of familial partial lipodystrophy, Adipocytokine profile and 3 more. Planned start May 2010; status: not yet recruiting.
02
Conditions
familial partial lipodystrophy (FPLD)
Beyond the preview
Go deeper on NL-OMON34111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34111.